Hypertrophic Cardiomyopathy (HCM)

A genetic disease characterized by abnormal thickening of the heart wall, often leading to arrhythmias and sudden cardiac death.

Services: Genetic testing, CMR-based risk stratification, medication, and interventional therapy.

Dilated Cardiomyopathy (DCM)

Characterized by ventricular dilation and systolic dysfunction, caused by genetic, viral, or autoimmune factors.

Services: Tissue biopsy, advanced HF therapy, device implantation (CRT/ICD), and remote monitoring.

Restrictive Cardiomyopathy (RCM)

A condition with impaired ventricular compliance, often secondary to infiltrative or metabolic diseases.

Services: Noninvasive imaging and serological workup for etiological diagnosis and tailored therapy.

Cardiac Amyloidosis

Caused by abnormal protein deposits in the myocardium, often misdiagnosed as hypertensive heart disease.

Services: CMR and bone scintigraphy, multidisciplinary evaluation, and access to novel targeted drugs.

Inflammatory/Giant Cell Myocarditis

Rapid-onset myocarditis that can lead to acute heart failure or cardiogenic shock.

Services: Emergency diagnostic pathway, myocardial biopsy, and immunosuppressive therapy guidance.

Left Ventricular Noncompaction (LVNC)

A congenital condition featuring spongy myocardium and risk of arrhythmia and HF.

Services: Precise diagnosis by CMR, long-term arrhythmia surveillance, and functional monitoring.

Genetic Cardiomyopathies

Includes LMNA, TTN, and other gene mutations with familial patterns and variable onset.

Services: Family-based genetic screening, whole-exome sequencing, and tailored prevention strategies.

Heart Failure (All Stages)

From high-risk asymptomatic individuals to end-stage HF requiring mechanical support.

Services: Early risk stratification, optimized pharmacologic therapy, rehab, and device therapy.